Xiang, Wei – Trademark Portfolio
Entity Type: 01
Xiang, Wei owns a portfolio of 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as FEUFOAM, MOMLOVES, and NOVOQUAD. Of these, 4 are registered. The portfolio spans 7 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 11 (Environmental Control). Headquartered in Ningbo.
1078 Changjiang Road, Beilun District
Ningbo 315899 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiang, Wei's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Advertising; business management; business administration; office functions
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Xiang, Wei have?
Xiang, Wei has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 1 cancelled.
What trademark classes does Xiang, Wei file in?
Xiang, Wei files trademarks across 7 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 35 (Advertising & Business), Class 18 (Leather Goods), Class 38 (Telecommunications). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Xiang, Wei's most well-known trademarks?
Xiang, Wei's registered trademark portfolio includes well-known marks such as FEUFOAM, MOMLOVES, and NOVOQUAD. These are among 4 currently registered trademarks in the portfolio.
What is Xiang, Wei's trademark registration success rate?
Xiang, Wei has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.